Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × Brachytherapy × Clear all

Phase

Status

Completed 5 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 16 Prostatic Neoplasms 5 Neoplasms 2 Uveitis 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer 1 Sarcoma 1 Salivary Gland Neoplasms 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Obesity 1 Neurotoxicity Syndromes 1 Liver Neoplasms 1 Hyperthermia 1 Gliosarcoma 1 Glioblastoma 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Clear Cell Adenocarcinoma 1 Choroid Neoplasms 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Doxorubicin 14 Radiotherapy 9 Ifosfamide 9 Cyclophosphamide 8 apatinib 7 anlotinib 7 Vincristine 5 Dactinomycin 5 toripalimab 3 camrelizumab 3 Trabectedin 3 Etoposide 3 Docetaxel 3 brostallicin 2 Topotecan 2 Temozolomide 2 Sorafenib 2 Radiation Dose Hypofractionation 2 Oncolytic Virotherapy 2 Nivolumab 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Gene Expression Profiling 2 Gemcitabine 2 Drug Therapy 2 Busulfan 2 Amplified Fragment Length Polymorphism Analysis 2 trofosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01552239 2018-10-16

PREMISS

Technical University of Munich

Phase 2 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡